Technology

Latest News


Finding the Best Path Forward for Adoption of Prescription Digital Therapeutics

Delve into the current state of prescription digital therapeutics (PDTs) adoption and uncover strategies for increasing payer approval and achieving widespread coverage of PDTs.

Finding the Best Path Forward for Adoption of Prescription Digital Therapeutics

Latest Videos



More News

Electronic health record (EHR)-based comorbidity assessment had low sensitivity for identifying major comorbidities and poorly predicted survival. EHR-based comorbidity data require validation prior to application to risk adjustment.

This week, the top managed care stories included the elimination of the Affordable Care Act's individual mandate; a new gene therapy for inherited vision loss that could cost $1 million; and a study found that social isolation can increase the risk of type 2 diabetes.

Electronic health records can be used to measure and record how guidelines are being implemented and followed, but more government intervention is needed to regulate electronic health records and set standards, Derek Raghavan, MD, PhD, FACP, FRACP, president, Carolinas HealthCare System's Levine Cancer Institute.

A practice must be prepared for any disruption of the electronic medical record, and have a plan in place, even if it doesn't occur often, saidTeri Kovach, RN, OCN, compliance officer and charge nurse at Salish Cancer Center.

While technology and electronic health records will one day be used in a variety of ways can help improve the delivery of care to patients, this may take a long time, said Bobby Green, MD, MSCE, senior vice president of clinical oncology at Flatiron Health.

Getting people on board when a new electronic health record (EHR) is being implemented is one of the biggest obstacles to overcome and is important for the success of the new EHR, said Teri Kovach, RN, OCN, compliance officer and charge nurse at Salish Cancer Center.

Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo